beta

INCY

Incyte Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. we have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. the incyte corporate headquarters is located in wilmington, delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders. for more information about incyte, please visit our corporate website at www.incyte.com.

Market Cap: 13.3 Billion

Primary Exchange: NASDAQ

Website: https://www.incyte.com/

Shares Outstanding: 225 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.4960416466638585

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Ethical Flags

Longest drawdown: 2111 trading days

From: 2017-03-15 To: 2024-03-07

Lowest Point:

Concert Pharmaceuticals: Cheap Valuation With Multiple Programs Moving Forward

via: SeekingAlpha at 2019-06-13 09:46:22:000

Shares of Concert Pharmaceuticals ( CNCE ) have provided quite the roller coaster ride for investors. The stock was a winner for us the first time around , as it tripled after my original recommendation (due to a lucrative deal inked with Vertex Pharmaceuticals (VRTX)). Subsequent recommendat… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud